Oregon Public Employees Retirement Fund Buys 7,896 Shares of Agilent Technologies, Inc. $A

Oregon Public Employees Retirement Fund boosted its position in Agilent Technologies, Inc. (NYSE:A) by 32.1% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 32,526 shares of the medical research company’s stock after buying an additional 7,896 shares during the period. Oregon Public Employees Retirement Fund’s holdings in Agilent Technologies were worth $4,175,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Capital A Wealth Management LLC raised its position in shares of Agilent Technologies by 10,600.0% during the second quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock worth $25,000 after purchasing an additional 212 shares during the period. Davis Capital Management acquired a new position in Agilent Technologies during the third quarter worth $28,000. Central Pacific Bank Trust Division bought a new position in shares of Agilent Technologies in the second quarter valued at $33,000. State of Wyoming acquired a new position in shares of Agilent Technologies during the second quarter valued at about $35,000. Finally, SJS Investment Consulting Inc. increased its position in shares of Agilent Technologies by 2,836.4% during the third quarter. SJS Investment Consulting Inc. now owns 323 shares of the medical research company’s stock worth $41,000 after acquiring an additional 312 shares in the last quarter.

Agilent Technologies Stock Up 1.9%

Shares of NYSE A opened at $148.56 on Friday. The company has a quick ratio of 1.52, a current ratio of 1.96 and a debt-to-equity ratio of 0.45. The company has a market cap of $42.12 billion, a P/E ratio of 32.51, a P/E/G ratio of 4.31 and a beta of 1.29. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $160.27. The business has a 50-day simple moving average of $144.55 and a two-hundred day simple moving average of $132.55.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.58 by $0.01. The firm had revenue of $1.86 billion for the quarter, compared to the consensus estimate of $1.83 billion. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The company’s revenue for the quarter was up 9.4% on a year-over-year basis. During the same period in the prior year, the firm posted $1.46 earnings per share. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Research analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th will be given a dividend of $0.255 per share. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.25. The ex-dividend date is Tuesday, January 6th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.32%.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on A. Bank of America raised their price target on shares of Agilent Technologies from $150.00 to $165.00 and gave the company a “neutral” rating in a research report on Tuesday, November 25th. JPMorgan Chase & Co. upped their price target on Agilent Technologies from $165.00 to $180.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. Evercore ISI upgraded Agilent Technologies from an “in-line” rating to an “outperform” rating and raised their price objective for the company from $155.00 to $160.00 in a research note on Monday, January 5th. TD Cowen upped their price objective on shares of Agilent Technologies from $150.00 to $162.00 and gave the stock a “buy” rating in a research report on Tuesday, October 14th. Finally, The Goldman Sachs Group started coverage on shares of Agilent Technologies in a research note on Tuesday, December 9th. They issued a “buy” rating and a $170.00 price objective for the company. One equities research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $163.31.

Insider Buying and Selling at Agilent Technologies

In related news, VP Rodney Gonsalves sold 3,000 shares of the business’s stock in a transaction dated Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total transaction of $464,970.00. Following the completion of the transaction, the vice president directly owned 31,846 shares in the company, valued at $4,935,811.54. The trade was a 8.61% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Padraig Mcdonnell sold 12,490 shares of the company’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total value of $1,873,500.00. Following the completion of the transaction, the chief executive officer owned 33,448 shares in the company, valued at $5,017,200. This represents a 27.19% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 16,401 shares of company stock worth $2,468,962.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.